Znanstveni rad - Pregledni rad
Clinical relevance of natural killer cells in breast cancer
Medicina Fluminensis, 58 (2022), 2; 113-120. https://doi.org/10.21860/medflum2022_275128


Citirajte ovaj rad

Gulić, T., Grebić, D., Starčević, A., Avirović, M., Valković Zujić, P., Veljković Vujaklija, D. i Blagojević Zagorac, G. (2022). Clinical relevance of natural killer cells in breast cancer. Medicina Fluminensis, 58. (2), 113-120. doi: 10.21860/medflum2022_275128

Gulić, Tamara, et al. "Clinical relevance of natural killer cells in breast cancer." Medicina Fluminensis, vol. 58, br. 2, 2022, str. 113-120. https://doi.org/10.21860/medflum2022_275128

Gulić, Tamara, Damir Grebić, Alma Starčević, Manuela Avirović, Petra Valković Zujić, Danijela Veljković Vujaklija i Gordana Blagojević Zagorac. "Clinical relevance of natural killer cells in breast cancer." Medicina Fluminensis 58, br. 2 (2022): 113-120. https://doi.org/10.21860/medflum2022_275128

Gulić, T., et al. (2022) 'Clinical relevance of natural killer cells in breast cancer', Medicina Fluminensis, 58(2), str. 113-120. doi: 10.21860/medflum2022_275128

Gulić T, Grebić D, Starčević A, Avirović M, Valković Zujić P, Veljković Vujaklija D, i sur.. Clinical relevance of natural killer cells in breast cancer. Medicina Fluminensis [Internet]. 2022. [pristupljeno 04.12.2024.];58(2):113-120. doi: 10.21860/medflum2022_275128

T. Gulić, et al., "Clinical relevance of natural killer cells in breast cancer", Medicina Fluminensis, vol. 58, br. 2, str. 113-120, 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:337098. [Citirano: 04.12.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.